评论：丹麦癌症患者中的大麻使用情况：社会人口学特征、生活质量及患者体验的横断面调查 - Suppr

Suppr

超能文献

Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences.

作者信息

Vitetta Luis, Sikali Jason F, Fletcher Courtney, Henson Jeremy D

机构信息

Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Research Department, Medlab Clinical, Sydney, Australia.

出版信息

Support Care Cancer. 2022 Nov;30(11):8619-8621. doi: 10.1007/s00520-022-06995-7. Epub 2022 Mar 21.

DOI:10.1007/s00520-022-06995-7

PMID:35312856

Abstract

摘要

相似文献

Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences.

Support Care Cancer. 2022 Nov;30(11):8619-8621. doi: 10.1007/s00520-022-06995-7. Epub 2022 Mar 21.

Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.

J Anal Toxicol. 2022 May 20;46(5):494-503. doi: 10.1093/jat/bkab059.

Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.

PLoS One. 2022 Oct 14;17(10):e0270543. doi: 10.1371/journal.pone.0270543. eCollection 2022.

Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences.

Support Care Cancer. 2022 Feb;30(2):1181-1190. doi: 10.1007/s00520-021-06515-z. Epub 2021 Aug 28.

Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.

Front Biosci (Landmark Ed). 2022 Jul 25;27(8):228. doi: 10.31083/j.fbl2708228.

Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.

Intern Med J. 2020 Jul;50(7):846-853. doi: 10.1111/imj.14415.

Acute effects of Δ-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity.

Psychopharmacology (Berl). 2022 May;239(5):1409-1424. doi: 10.1007/s00213-021-05997-3. Epub 2021 Nov 1.

Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use.

Forensic Sci Int. 2022 Apr;333:111237. doi: 10.1016/j.forsciint.2022.111237. Epub 2022 Feb 19.

Comment on Lachenmeier (2020) "Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?": disputation on various points in the publication.

F1000Res. 2020 Aug 4;9:900. doi: 10.12688/f1000research.25354.1. eCollection 2020.

Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.

Eur Neuropsychopharmacol. 2008 Aug;18(8):569-77. doi: 10.1016/j.euroneuro.2008.04.008. Epub 2008 Jun 10.

引用本文的文献

Comment on "Hall et al., Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain".

J Cannabis Res. 2024 Mar 18;6(1):13. doi: 10.1186/s42238-023-00206-8.

本文引用的文献

The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.

J Natl Cancer Inst Monogr. 2021 Nov 28;2021(58):86-98. doi: 10.1093/jncimonographs/lgab011.

Sociodemographic Characteristics Associated With and Prevalence and Frequency of Cannabis Use Among Adults in the US.

JAMA Netw Open. 2021 Nov 1;4(11):e2136571. doi: 10.1001/jamanetworkopen.2021.36571.

Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences.

Support Care Cancer. 2022 Feb;30(2):1181-1190. doi: 10.1007/s00520-021-06515-z. Epub 2021 Aug 28.

Comment on: Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in patients with chronic pain.

Can J Anaesth. 2021 Nov;68(11):1707-1708. doi: 10.1007/s12630-021-02078-z. Epub 2021 Aug 4.

Growing pains: An overview of cannabis quality control and quality assurance in Canada.

Int J Drug Policy. 2021 Jul;93:103111. doi: 10.1016/j.drugpo.2021.103111. Epub 2021 Jan 18.

Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients.

Can J Anaesth. 2021 May;68(5):633-644. doi: 10.1007/s12630-020-01903-1. Epub 2021 Jan 20.

Therapeutic potential of cannabinoids in combination cancer therapy.

Adv Biol Regul. 2021 Jan;79:100774. doi: 10.1016/j.jbior.2020.100774. Epub 2021 Jan 6.

Druggable Targets in Endocannabinoid Signaling.

Adv Exp Med Biol. 2020;1274:177-201. doi: 10.1007/978-3-030-50621-6_8.

Communicating THC levels and 'dose' to consumers: Implications for product labelling and packaging of cannabis products in regulated markets.

Int J Drug Policy. 2021 May;91:102509. doi: 10.1016/j.drugpo.2019.07.004. Epub 2019 Jul 25.

Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects.

Br J Clin Pharmacol. 2018 Nov;84(11):2468-2476. doi: 10.1111/bcp.13695. Epub 2018 Aug 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences.

作者信息

Vitetta Luis, Sikali Jason F, Fletcher Courtney, Henson Jeremy D

机构信息

Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Research Department, Medlab Clinical, Sydney, Australia.

出版信息

Support Care Cancer. 2022 Nov;30(11):8619-8621. doi: 10.1007/s00520-022-06995-7. Epub 2022 Mar 21.

DOI:10.1007/s00520-022-06995-7

PMID:35312856

Abstract

摘要

相似文献

Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences.

Support Care Cancer. 2022 Nov;30(11):8619-8621. doi: 10.1007/s00520-022-06995-7. Epub 2022 Mar 21.

Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.

J Anal Toxicol. 2022 May 20;46(5):494-503. doi: 10.1093/jat/bkab059.

Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.

PLoS One. 2022 Oct 14;17(10):e0270543. doi: 10.1371/journal.pone.0270543. eCollection 2022.

Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences.

Support Care Cancer. 2022 Feb;30(2):1181-1190. doi: 10.1007/s00520-021-06515-z. Epub 2021 Aug 28.

Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.

Front Biosci (Landmark Ed). 2022 Jul 25;27(8):228. doi: 10.31083/j.fbl2708228.

Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.

Intern Med J. 2020 Jul;50(7):846-853. doi: 10.1111/imj.14415.

Acute effects of Δ-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity.

Psychopharmacology (Berl). 2022 May;239(5):1409-1424. doi: 10.1007/s00213-021-05997-3. Epub 2021 Nov 1.

Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use.

Forensic Sci Int. 2022 Apr;333:111237. doi: 10.1016/j.forsciint.2022.111237. Epub 2022 Feb 19.

Comment on Lachenmeier (2020) "Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?": disputation on various points in the publication.

F1000Res. 2020 Aug 4;9:900. doi: 10.12688/f1000research.25354.1. eCollection 2020.

Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.

Eur Neuropsychopharmacol. 2008 Aug;18(8):569-77. doi: 10.1016/j.euroneuro.2008.04.008. Epub 2008 Jun 10.

引用本文的文献

Comment on "Hall et al., Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain".

J Cannabis Res. 2024 Mar 18;6(1):13. doi: 10.1186/s42238-023-00206-8.

本文引用的文献

The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.

J Natl Cancer Inst Monogr. 2021 Nov 28;2021(58):86-98. doi: 10.1093/jncimonographs/lgab011.

Sociodemographic Characteristics Associated With and Prevalence and Frequency of Cannabis Use Among Adults in the US.

JAMA Netw Open. 2021 Nov 1;4(11):e2136571. doi: 10.1001/jamanetworkopen.2021.36571.

Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences.

Support Care Cancer. 2022 Feb;30(2):1181-1190. doi: 10.1007/s00520-021-06515-z. Epub 2021 Aug 28.

Comment on: Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in patients with chronic pain.

Can J Anaesth. 2021 Nov;68(11):1707-1708. doi: 10.1007/s12630-021-02078-z. Epub 2021 Aug 4.

Growing pains: An overview of cannabis quality control and quality assurance in Canada.

Int J Drug Policy. 2021 Jul;93:103111. doi: 10.1016/j.drugpo.2021.103111. Epub 2021 Jan 18.

Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients.

Can J Anaesth. 2021 May;68(5):633-644. doi: 10.1007/s12630-020-01903-1. Epub 2021 Jan 20.

Therapeutic potential of cannabinoids in combination cancer therapy.

Adv Biol Regul. 2021 Jan;79:100774. doi: 10.1016/j.jbior.2020.100774. Epub 2021 Jan 6.

Druggable Targets in Endocannabinoid Signaling.

Adv Exp Med Biol. 2020;1274:177-201. doi: 10.1007/978-3-030-50621-6_8.

Communicating THC levels and 'dose' to consumers: Implications for product labelling and packaging of cannabis products in regulated markets.

Int J Drug Policy. 2021 May;91:102509. doi: 10.1016/j.drugpo.2019.07.004. Epub 2019 Jul 25.

Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects.

Br J Clin Pharmacol. 2018 Nov;84(11):2468-2476. doi: 10.1111/bcp.13695. Epub 2018 Aug 1.